Carregant...
Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer
Estrogen receptor (ER) is the most important factor in the pathophysiology of breast cancer. Consequently, modulation of ER activity has been exploited to develop drugs against ER+ breast cancer, such as tamoxifen, referred to as endocrine therapies. With deeper understanding of ER mechanism of acti...
Guardat en:
| Publicat a: | Mol Cell Endocrinol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368394/ https://ncbi.nlm.nih.gov/pubmed/30659843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2019.01.014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|